On the public citation graph

Molecular Mechanisms of Sars-Cov-2-Induced Surfactant Inhibition

https://doi.org/10.2139/ssrn.4783817
0 signed · 41 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2020.8907openalex-extracted
Postmortem Examination of Patients With COVID-19
inferredcites →https://doi.org/10.1002/elps.202100015openalex-extracted
Isoelectric point determination by imaged CIEF of commercially available SARS‐CoV‐2 proteins and the hACE2 receptor
inferredcites →https://doi.org/10.1016/j.bbalip.2022.159139openalex-extracted
Anti-inflammatory and anti-viral actions of anionic pulmonary surfactant phospholipids
inferredcites →https://doi.org/10.1016/j.bbamem.2008.03.021openalex-extracted
Current perspectives in pulmonary surfactant — Inhibition, enhancement and evaluation
inferredcites →https://doi.org/10.1016/j.bbamem.2011.03.006openalex-extracted
Comparative study of clinical pulmonary surfactants using atomic force microscopy
inferredcites →https://doi.org/10.1016/j.bpj.2021.02.041openalex-extracted
Binding mode of SARS-CoV-2 fusion peptide to human cellular membrane
inferredcites →https://doi.org/10.1016/j.cell.2020.05.042openalex-extracted
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
inferredcites →https://doi.org/10.1016/j.chest.2021.01.028openalex-extracted
Surfactant for the Treatment of ARDS in a Patient With COVID-19
inferredcites →https://doi.org/10.1016/j.jcis.2023.06.121openalex-extracted
Adsorption of Pulmonary and Exogeneous Surfactants on SARS-CoV-2 Spike Protein
inferredcites →https://doi.org/10.1016/j.jconrel.2021.11.023openalex-extracted
Pulmonary surfactant as a versatile biomaterial to fight COVID-19
inferredcites →https://doi.org/10.1016/j.resp.2021.103645openalex-extracted
Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury
inferredcites →https://doi.org/10.1016/j.rmed.2021.106489openalex-extracted
Beneficial effects of inhaled surfactant in patients with COVID-19-associated acute respiratory distress syndrome
inferredcites →https://doi.org/10.1016/s0925-4439(98)00061-1openalex-extracted
The role of lipids in pulmonary surfactant
inferredcites →https://doi.org/10.1021/acs.chemrev.3c00146openalex-extracted
Pulmonary Surfactant: A Mighty Thin Film
inferredcites →https://doi.org/10.1021/acs.jpcb.1c04176openalex-extracted
Binding of SARS-CoV-2 Fusion Peptide to Host Endosome and Plasma Membrane
inferredcites →https://doi.org/10.1021/acs.jpclett.2c01998openalex-extracted
S2 Subunit of SARS-CoV-2 Spike Protein Induces Domain Fusion in Natural Pulmonary Surfactant Monolayers
inferredcites →https://doi.org/10.1021/acs.langmuir.6b01215openalex-extracted
Automated Droplet Manipulation Using Closed-Loop Axisymmetric Drop Shape Analysis
inferredcites →https://doi.org/10.1021/acsnano.5b01181openalex-extracted
Biophysical Influence of Airborne Carbon Nanomaterials on Natural Pulmonary Surfactant
inferredcites →https://doi.org/10.1038/s41467-020-15562-9openalex-extracted
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
inferredcites →https://doi.org/10.1038/s41572-019-0069-0openalex-extracted
Acute respiratory distress syndrome
inferredcites →https://doi.org/10.1038/s41580-021-00418-xopenalex-extracted
Mechanisms of SARS-CoV-2 entry into cells
inferredcites →https://doi.org/10.1038/s41598-022-07944-4openalex-extracted
Reduced levels of pulmonary surfactant in COVID-19 ARDS
inferredcites →https://doi.org/10.1038/s41598-023-47672-xopenalex-extracted
A randomized controlled trial of nebulized surfactant for the treatment of severe COVID-19 in adults (COVSurf trial)
inferredcites →https://doi.org/10.1042/bsr20230504openalex-extracted
Surfactant replacement therapy as promising treatment for COVID-19: an updated narrative review
inferredcites →https://doi.org/10.1056/nejmcp2009575openalex-extracted
Severe Covid-19
inferredcites →https://doi.org/10.1074/jbc.aw118.003229openalex-extracted
Phospholipid regulation of innate immunity and respiratory viral infection
inferredcites →https://doi.org/10.1080/17476348.2021.1865809openalex-extracted
The COVID-19 pandemic: a target for surfactant therapy?
inferredcites →https://doi.org/10.1126/science.abd4251openalex-extracted
Distinct conformational states of SARS-CoV-2 spike protein
inferredcites →https://doi.org/10.1136/thx.2006.062398openalex-extracted
Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids
inferredcites →https://doi.org/10.1146/annurev.pc.42.100191.001131openalex-extracted
Structures And Transitions In Lipid Monolayers At The Air-Water Interface
inferredcites →https://doi.org/10.1146/annurev.physiol.65.092101.142434openalex-extracted
The Role of Exogenous Surfactant in the Treatment of Acute Lung Injury
inferredcites →https://doi.org/10.1152/ajplung.00101.2023openalex-extracted
Constrained drop surfactometry for studying adsorbed pulmonary surfactant at physiologically relevant high concentrations
inferredcites →https://doi.org/10.1152/jappl.1987.62.5.1878openalex-extracted
Relations among alveolar surface tension, surface area, volume, and recoil pressure
inferredcites →https://doi.org/10.1164/rccm.202110-2279leopenalex-extracted
Rapid Phospholipid Turnover after Surfactant Nebulization in Severe COVID-19 Infection: A Randomized Clinical Trial
inferredcites →https://doi.org/10.1164/rccm.202201-0011ocopenalex-extracted
Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19
inferredcites →https://doi.org/10.1186/rr86openalex-extracted
Surfactant alteration and replacement in acute respiratory distress syndrome
inferredcites →https://doi.org/10.1186/s12931-020-01603-wopenalex-extracted
Surfactant therapy for COVID-19 related ARDS: a retrospective case–control pilot study
inferredcites →https://doi.org/10.1186/s13054-020-03240-7openalex-extracted
Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey
inferredcites →https://doi.org/10.1203/00006450-199907000-00015openalex-extracted
Multiple Mechanisms of Lung Surfactant Inhibition
inferredcites →https://doi.org/10.14740/jocmr4915openalex-extracted
The Contribution of COVID-19 to Acute Respiratory Distress Syndrome-Related Mortality in the United States
inferredcites →https://doi.org/10.1513/annalsats.201512-841ocopenalex-extracted
Mortality Trends of Acute Respiratory Distress Syndrome in the United States from 1999 to 2013
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.